Indication
Retinitis
2 clinical trials
1 product
Product
MCO-010Clinical trial
A Phase 2b Randomized, Double-Masked, Sham-Controlled, Study to Evaluate the Efficacy and Safety of Intravitreal Injection of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]Status: Completed, Estimated PCD: 2023-02-27
Clinical trial
Long Term Follow-up for Subjects Who Previously Participated in the NTXMCO-002 RESTORE StudyStatus: , Estimated PCD: 2027-07-01